Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.
Also called NCT03186742
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 125 participants
- Registry
-
NCT03186742
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT03186742. Randomized; no masking; primary purpose treatment. Start 2014-07-01 (actual); primary completion 2017-01-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Reduction of Left Ventricular Hypertrophy After Eplerenone Therapy
- Condition
- Hypertension,Essential
- Condition
- Obstructive Sleep Apnea
- Condition
- Left Ventricular Hypertrophy
- Intervention (Drug)
- Eplerenone 50 mg Tab
- Lead sponsor
- Poznan University of Medical Sciences
Record details
- Record id
cardio:ct-nct03186742- Content hash
2137d8c2067cd60d4106c969b9d75a656df749fa38d35503c93d5ad5e3f0e369